Amanote Research
Register
Sign In
Converting-Enzyme Inhibitors in the Treatment of Hypertension
New England Journal of Medicine
- United States
doi 10.1056/nejm198906293202609
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
June 29, 1989
Authors
Unknown
Publisher
Massachusetts Medical Society
Related search
Angiotensin Converting Enzyme Inhibitors for Cancer Treatment?
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Angiotensin Converting Enzyme (ACE) Inhibitors
Annual Review of Pharmacology and Toxicology
Toxicology
Pharmacology
Dosage of Angiotensin Converting Enzyme Inhibitors
BMJ
Oral Converting Enzyme Inhibitor in Malignant Hypertension.
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Antioxidant Power of Angiotensin-Converting Enzyme Inhibitors in Vitro
British Journal of Clinical Pharmacology
Pharmacology
Updates on the Treatment of Essential Hypertension: A Summary of AHRQ’s Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Direct Renin Inhibitors
Journal of Managed Care Pharmacy
Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.
BMJ
N-Protected Tripeptide Inhibitors of Angiotensin Converting Enzyme.
Agricultural and Biological Chemistry
Angiotensin-Converting Enzyme Inhibitors and Angioedema: Estimating the Risk
Hypertension
Internal Medicine
